back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2018-02-06 Tx date 2018-01-23 |
$VBV
VBI Vaccines Inc. |
Kartsaklis, Athena
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
75,000 | |
| Filed 2018-02-06 Tx date 2017-09-21 |
$VBV
VBI Vaccines Inc. |
Kartsaklis, Athena
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-02-06 Tx date 2017-09-21 |
$VBV
VBI Vaccines Inc. |
Kartsaklis, Athena
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-02-02 Tx date 2018-01-23 |
$VBV
VBI Vaccines Inc. |
Kariv, Tomer
4 - Director of Issuer
Holder: Pontifax (China) IV Limited Partnership (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
146,667 | ||
| Filed 2018-02-02 Tx date 2018-01-23 |
$VBV
VBI Vaccines Inc. |
Kariv, Tomer
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
75,000 | |
| Filed 2018-02-02 Tx date 2017-03-30 |
$VBV
VBI Vaccines Inc. |
Avi, Mazaltov
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
6,000 | ||
| Filed 2018-02-02 Tx date 2017-03-30 |
$VBV
VBI Vaccines Inc. |
Avi, Mazaltov
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-02-02 Tx date 2018-01-23 |
$VBV
VBI Vaccines Inc. |
Avi, Mazaltov
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
100,000 | |
| Filed 2018-02-02 Tx date 2017-03-30 |
$VBV
VBI Vaccines Inc. |
Avi, Mazaltov
5 - Senior Officer of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
24,000 | ||
| Filed 2018-02-02 Tx date 2018-01-23 |
$VBV
VBI Vaccines Inc. |
Kariv, Tomer
4 - Director of Issuer
Holder: Pontifax (Cayman) IV Limited (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
551,089 | ||
| Filed 2018-02-02 Tx date 2018-01-23 |
$VBV
VBI Vaccines Inc. |
Kariv, Tomer
4 - Director of Issuer
Holder: Pontifax (China) IV Limited Partnership (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
612,022 | ||
| Filed 2018-02-02 Tx date 2018-01-23 |
$VBV
VBI Vaccines Inc. |
Kariv, Tomer
4 - Director of Issuer
Holder: Pontifax (Israel) IV Limited (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,131,972 | ||
| Filed 2018-02-02 Tx date 2018-01-23 |
$VBV
VBI Vaccines Inc. |
Kariv, Tomer
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-02-02 Tx date 2018-01-23 |
$VBV
VBI Vaccines Inc. |
Kariv, Tomer
4 - Director of Issuer
Holder: Pontifax (Cayman) IV Limited (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
132,064 | ||
| Filed 2018-02-02 Tx date 2018-01-23 |
$VBV
VBI Vaccines Inc. |
Kariv, Tomer
4 - Director of Issuer
Holder: Pontifax (Israel) IV Limited (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
271,269 | ||
| Filed 2018-01-26 Tx date 2017-09-21 |
$VBV
VBI Vaccines Inc. |
Beattie, Nell
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
6,250 | ||
| Filed 2018-01-26 Tx date 2018-01-23 |
$VBV
VBI Vaccines Inc. |
Beattie, Nell
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
120,000 | |
| Filed 2018-01-26 Tx date 2018-01-23 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
869,648 | |
| Filed 2018-01-26 Tx date 2017-09-21 |
$VBV
VBI Vaccines Inc. |
Beattie, Nell
5 - Senior Officer of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
12,500 | ||
| Filed 2018-01-26 Tx date 2018-01-23 |
$VBV
VBI Vaccines Inc. |
De Wilde, Michel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
129,116 | |
| Filed 2018-01-26 Tx date 2018-01-23 |
$VBV
VBI Vaccines Inc. |
Diaz-Mitoma, Francisco
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
120,000 | |
| Filed 2018-01-26 Tx date 2018-01-23 |
$VBV
VBI Vaccines Inc. |
Gillis, Steven
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
208,027 | |
| Filed 2018-01-26 Tx date 2018-01-23 |
$VBV
VBI Vaccines Inc. |
Logal, Adam
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
87,500 | |
| Filed 2018-01-26 Tx date 2018-01-23 |
$VBV
VBI Vaccines Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
87,500 | |
| Filed 2018-01-26 Tx date 2018-01-23 |
$VBV
VBI Vaccines Inc. |
Rubin, Steven Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
87,500 | |
| Filed 2018-01-26 Tx date 2017-09-21 |
$VBV
VBI Vaccines Inc. |
Beattie, Nell
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
20,000 | ||
| Filed 2018-01-26 Tx date 2018-01-23 |
$VBV
VBI Vaccines Inc. |
Anderson, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
463,311 | |
| Filed 2017-12-13 Tx date 2017-12-12 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,882
+4,609 vol $3.88 each |
145,255 | |
| Filed 2017-12-13 Tx date 2017-12-12 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,970
+5,391 vol $3.89 each |
140,646 | |
| Filed 2017-11-29 Tx date 2017-11-28 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$71,250
+15,000 vol $4.75 each |
135,255 | |
| Filed 2017-08-23 Tx date 2017-08-10 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$32,800
+10,000 vol $3.28 each |
110,255 | |
| Filed 2017-08-23 Tx date 2017-08-21 |
$VBV
VBI Vaccines Inc. |
Diaz-Mitoma, Francisco
5 - Senior Officer of Issuer
Holder: F. Diaz-Mitoma Medicine Professional Corporation (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,510
+3,000 vol $3.17 each |
3,000 | |
| Filed 2017-08-23 Tx date 2017-08-21 |
$VBV
VBI Vaccines Inc. |
Diaz-Mitoma, Francisco
5 - Senior Officer of Issuer
Holder: F. Diaz-Mitoma Medicine Professional Corporation (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,510
+3,000 vol $3.17 each |
||
| Filed 2017-08-23 Tx date 2017-08-21 |
$VBV
VBI Vaccines Inc. |
Diaz-Mitoma, Francisco
5 - Senior Officer of Issuer
Holder: F. Diaz-Mitoma Medicine Professional Corporation (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,510
+3,000 vol $3.17 each |
||
| Filed 2017-08-23 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
Diaz-Mitoma, Francisco
5 - Senior Officer of Issuer
Holder: F. Diaz-Mitoma Medicine Professional Corporation (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-08-23 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
Diaz-Mitoma, Francisco
5 - Senior Officer of Issuer
Holder: F. Diaz-Mitoma Medicine Professional Corporation (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-08-23 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
Diaz-Mitoma, Francisco
5 - Senior Officer of Issuer
Holder: F. Diaz-Mitoma Medicine Professional Corporation (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-08-23 Tx date 2017-08-21 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$32,200
+10,000 vol $3.22 each |
120,255 | |
| Filed 2017-06-23 Tx date 2017-06-23 |
$VBV
VBI Vaccines Inc. |
Diaz-Mitoma, Francisco
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
+12,500 vol |
264,339 | |
| Filed 2017-06-16 Tx date 2017-06-14 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
57 - Exercise of rights
|
-31,250 vol |
62,500 | |
| Filed 2017-06-16 Tx date 2017-06-14 |
$VBV
VBI Vaccines Inc. |
Rubin, Steven Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
57 - Exercise of rights
|
-18,750 vol |
37,500 | |
| Filed 2017-06-16 Tx date 2017-06-14 |
$VBV
VBI Vaccines Inc. |
Rubin, Steven Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+18,750 vol |
37,500 | |
| Filed 2017-06-16 Tx date 2017-06-14 |
$VBV
VBI Vaccines Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
57 - Exercise of rights
|
-12,500 vol |
25,000 | |
| Filed 2017-06-16 Tx date 2017-06-14 |
$VBV
VBI Vaccines Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+12,500 vol |
25,000 | |
| Filed 2017-06-16 Tx date 2017-06-14 |
$VBV
VBI Vaccines Inc. |
Logal, Adam
4 - Director of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
57 - Exercise of rights
|
-12,500 vol |
25,000 | |
| Filed 2017-06-16 Tx date 2017-06-14 |
$VBV
VBI Vaccines Inc. |
Logal, Adam
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+12,500 vol |
25,000 | |
| Filed 2017-06-16 Tx date 2017-06-14 |
$VBV
VBI Vaccines Inc. |
Gillis, Steven
4 - Director of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
57 - Exercise of rights
|
-18,750 vol |
37,500 | |
| Filed 2017-06-16 Tx date 2017-06-14 |
$VBV
VBI Vaccines Inc. |
Gillis, Steven
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+18,750 vol |
46,916 | |
| Filed 2017-06-16 Tx date 2017-06-14 |
$VBV
VBI Vaccines Inc. |
De Wilde, Michel
4 - Director of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
57 - Exercise of rights
|
-12,500 vol |
25,000 | |
| Filed 2017-06-16 Tx date 2017-06-14 |
$VBV
VBI Vaccines Inc. |
De Wilde, Michel
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+12,500 vol |
25,000 | |
| Filed 2017-06-16 Tx date 2017-06-14 |
$VBV
VBI Vaccines Inc. |
Chawla, Sam
4 - Director of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
57 - Exercise of rights
|
-12,500 vol |
25,000 | |
| Filed 2017-06-16 Tx date 2017-06-14 |
$VBV
VBI Vaccines Inc. |
Chawla, Sam
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+12,500 vol |
25,000 | |
| Filed 2017-06-16 Tx date 2017-06-14 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+31,250 vol |
100,255 | |
| Filed 2017-06-16 Tx date 2017-06-14 |
$VBV
VBI Vaccines Inc. |
Anderson, David
5 - Senior Officer of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
57 - Exercise of rights
|
-21,875 vol |
43,750 | |
| Filed 2017-06-16 Tx date 2017-06-14 |
$VBV
VBI Vaccines Inc. |
Anderson, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+21,875 vol |
94,552 | |
| Filed 2017-04-26 Tx date 2017-03-29 |
$VBV
VBI Vaccines Inc. |
Diaz-Mitoma, Francisco
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$56,625
+12,500 vol $4.53 each |
251,839 | |
| Filed 2017-04-21 Tx date 2015-07-14 |
$VBV
VBI Vaccines Inc. |
Logal, Adam
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-21 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
Logal, Adam
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$48,375
+12,500 vol $3.87 each |
12,500 | |
| Filed 2017-04-21 Tx date 2015-07-14 |
$VBV
VBI Vaccines Inc. |
Logal, Adam
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-21 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
Logal, Adam
4 - Director of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
56 - Grant of rights
|
+50,000 vol |
50,000 | |
| Filed 2017-04-21 Tx date 2015-07-14 |
$VBV
VBI Vaccines Inc. |
Logal, Adam
4 - Director of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-21 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
Logal, Adam
4 - Director of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
57 - Exercise of rights
|
$-48,375
-12,500 vol $3.87 each |
37,500 | |
| Filed 2017-04-21 Tx date 2017-01-26 |
$VBV
VBI Vaccines Inc. |
Logal, Adam
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,500 vol |
12,500 | |
| Filed 2017-04-19 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
Nascimento, Egidio
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
||
| Filed 2017-04-19 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
Nascimento, Egidio
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
348,991 | |
| Filed 2017-04-13 Tx date 2016-08-26 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,022
+550 vol $3.68 each |
51,430 | |
| Filed 2017-04-13 Tx date 2016-08-25 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,679
+1,000 vol $3.68 each |
50,880 | |
| Filed 2017-04-13 Tx date 2016-08-23 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,378
+1,440 vol $3.73 each |
49,880 | |
| Filed 2017-04-13 Tx date 2016-08-23 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,427
+1,440 vol $3.77 each |
48,440 | |
| Filed 2017-04-13 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$120,937
+31,250 vol $3.87 each |
47,000 | |
| Filed 2017-04-13 Tx date 2016-05-27 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,029
+2,520 vol $3.98 each |
15,750 | |
| Filed 2017-04-13 Tx date 2016-05-24 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,001
+2,850 vol $3.86 each |
13,230 | |
| Filed 2017-04-13 Tx date 2016-05-23 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,516
+376 vol $4.03 each |
10,380 | |
| Filed 2017-04-13 Tx date 2016-05-18 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,290
+5,000 vol $4.06 each |
10,004 | |
| Filed 2017-04-13 Tx date 2016-05-18 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,061
+5,000 vol $4.01 each |
5,004 | |
| Filed 2017-04-13 Tx date 2016-05-10 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+2 vol |
4 | |
| Filed 2017-04-13 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
57 - Exercise of rights
|
$-120,937.50
-31,250 vol $3.87 each |
93,750 | |
| Filed 2017-04-13 Tx date 2016-11-29 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,877
+2,400 vol $2.87 each |
69,005 | |
| Filed 2017-04-13 Tx date 2016-11-28 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,368
+6,700 vol $3.04 each |
66,605 | |
| Filed 2017-04-13 Tx date 2016-09-14 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,000
+1,325 vol $3.77 each |
59,905 | |
| Filed 2017-04-13 Tx date 2016-09-14 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$564.23
+150 vol $3.76 each |
58,580 | |
| Filed 2017-04-13 Tx date 2016-09-08 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,997
+750 vol $4.00 each |
58,430 | |
| Filed 2017-04-13 Tx date 2016-09-01 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,316
+4,000 vol $3.58 each |
57,680 | |
| Filed 2017-04-13 Tx date 2016-08-31 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,559
+1,000 vol $3.56 each |
53,680 | |
| Filed 2017-04-13 Tx date 2016-08-30 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,466
+1,250 vol $3.57 each |
52,680 | |
| Filed 2017-04-12 Tx date 2015-07-14 |
$VBV
VBI Vaccines Inc. |
Rubin, Steven Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-12 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
Gillis, Steven
4 - Director of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-12 Tx date 2017-01-17 |
$VBV
VBI Vaccines Inc. |
Gillis, Steven
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-15,942.50
-6,377 vol $2.50 each |
93,027 | |
| Filed 2017-04-12 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
Gillis, Steven
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$72,562
+18,750 vol $3.87 each |
21,789 | |
| Filed 2017-04-12 Tx date 2017-01-26 |
$VBV
VBI Vaccines Inc. |
Gillis, Steven
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
108,027 | |
| Filed 2017-04-12 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-12 Tx date 2016-05-09 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8.16
+2 vol $4.08 each |
2 | |
| Filed 2017-04-12 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
699,648 | ||
| Filed 2017-04-12 Tx date 2017-01-26 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
719,648 | |
| Filed 2017-04-12 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-12 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
Baxter, Jeffrey Royston
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
56 - Grant of rights
|
+125,000 vol |
125,000 | |
| Filed 2017-04-12 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
Gillis, Steven
4 - Director of Issuer
Holder: ARCH Venture Fund VI, L.P. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,168,144 | ||
| Filed 2017-04-12 Tx date 2016-06-20 |
$VBV
VBI Vaccines Inc. |
Gillis, Steven
4 - Director of Issuer
Holder: ARCH Venture Fund VI, L.P. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$2,214,287
+544,948 vol $4.06 each |
2,713,092 | |
| Filed 2017-04-12 Tx date 2016-12-07 |
$VBV
VBI Vaccines Inc. |
Gillis, Steven
4 - Director of Issuer
Holder: ARCH Venture Fund VI, L.P. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$52,680
+12,965 vol $4.06 each |
2,726,057 | |
| Filed 2017-04-12 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
Gillis, Steven
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
3,039 | ||
| Filed 2017-04-12 Tx date 2017-01-17 |
$VBV
VBI Vaccines Inc. |
Gillis, Steven
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$15,942
+6,377 vol $2.50 each |
28,166 | |
| Filed 2017-04-12 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
Gillis, Steven
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
99,404 | ||
| Filed 2017-04-12 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
Gillis, Steven
4 - Director of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
56 - Grant of rights
|
+75,000 vol |
75,000 | |
| Filed 2017-04-12 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
Gillis, Steven
4 - Director of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
57 - Exercise of rights
|
$-72,562.50
-18,750 vol $3.87 each |
56,250 | |
| Filed 2017-04-12 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
Lockshin, Curtis
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$54,447
+14,069 vol $3.87 each |
393,125 | |
| Filed 2017-04-12 Tx date 2016-12-22 |
$VBV
VBI Vaccines Inc. |
Lockshin, Curtis
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$35,428
+11,037 vol $3.21 each |
404,162 | |
| Filed 2017-04-12 Tx date 2015-07-14 |
$VBV
VBI Vaccines Inc. |
Lockshin, Curtis
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-12 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
Lockshin, Curtis
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
56 - Grant of rights
|
+112,500 vol |
112,500 | |
| Filed 2017-04-12 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
Lockshin, Curtis
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
57 - Exercise of rights
|
$-108,843.75
-28,125 vol $3.87 each |
84,375 | |
| Filed 2017-04-12 Tx date 2016-12-22 |
$VBV
VBI Vaccines Inc. |
Lockshin, Curtis
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
57 - Exercise of rights
|
$-47,241.57
-14,717 vol $3.21 each |
69,658 | |
| Filed 2017-04-12 Tx date 2016-12-22 |
$VBV
VBI Vaccines Inc. |
Lockshin, Curtis
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
58 - Expiration of rights
|
-69,658 vol |
0 | |
| Filed 2017-04-12 Tx date 2015-07-14 |
$VBV
VBI Vaccines Inc. |
Rubin, Steven Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-12 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
Rubin, Steven Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$72,562
+18,750 vol $3.87 each |
18,750 | |
| Filed 2017-04-12 Tx date 2017-01-26 |
$VBV
VBI Vaccines Inc. |
Rubin, Steven Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,500 vol |
12,500 | |
| Filed 2017-04-12 Tx date 2015-07-14 |
$VBV
VBI Vaccines Inc. |
Rubin, Steven Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-12 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
Rubin, Steven Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
56 - Grant of rights
|
+75,000 vol |
75,000 | |
| Filed 2017-04-12 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
Rubin, Steven Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
57 - Exercise of rights
|
$-72,562.50
-18,750 vol $3.87 each |
56,250 | |
| Filed 2017-04-07 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
Anderson, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$46,904
+12,120 vol $3.87 each |
61,052 | |
| Filed 2017-04-07 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
57 - Exercise of rights
|
$-48,375
-12,500 vol $3.87 each |
37,500 | |
| Filed 2017-04-07 Tx date 2017-01-26 |
$VBV
VBI Vaccines Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,500 vol |
12,500 | |
| Filed 2017-04-07 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-07 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$48,375
+12,500 vol $3.87 each |
12,500 | |
| Filed 2017-04-07 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-07 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
56 - Grant of rights
|
+50,000 vol |
50,000 | |
| Filed 2017-04-07 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-07 Tx date 2017-01-26 |
$VBV
VBI Vaccines Inc. |
Nascimento, Egidio
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
300,041 | |
| Filed 2017-04-07 Tx date 2016-12-22 |
$VBV
VBI Vaccines Inc. |
Nascimento, Egidio
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-13,950 vol |
280,041 | |
| Filed 2017-04-07 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
Nascimento, Egidio
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
293,991 | |
| Filed 2017-04-07 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
De Wilde, Michel
4 - Director of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
57 - Exercise of rights
|
$-48,375
-12,500 vol $3.87 each |
37,500 | |
| Filed 2017-04-07 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
De Wilde, Michel
4 - Director of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
56 - Grant of rights
|
+50,000 vol |
50,000 | |
| Filed 2017-04-07 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
De Wilde, Michel
4 - Director of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-07 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
De Wilde, Michel
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$48,375
+12,500 vol $3.87 each |
12,500 | |
| Filed 2017-04-07 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
De Wilde, Michel
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-07 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
Chawla, Sam
4 - Director of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
57 - Exercise of rights
|
$-48,375
-12,500 vol $3.87 each |
37,500 | |
| Filed 2017-04-07 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
Chawla, Sam
4 - Director of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
56 - Grant of rights
|
+50,000 vol |
50,000 | |
| Filed 2017-04-07 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
Chawla, Sam
4 - Director of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-07 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
Chawla, Sam
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$48,375
+12,500 vol $3.87 each |
12,500 | |
| Filed 2017-04-07 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
Chawla, Sam
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-07 Tx date 2016-12-07 |
$VBV
VBI Vaccines Inc. |
Chawla, Sam
4 - Director of Issuer
Holder: Perceptive Life Sciences Master Fund Ltd. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$131,695
+32,411 vol $4.06 each |
6,245,725 | |
| Filed 2017-04-07 Tx date 2016-06-21 |
$VBV
VBI Vaccines Inc. |
Chawla, Sam
4 - Director of Issuer
Holder: Perceptive Life Sciences Master Fund Ltd. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$5,670,728
+1,362,370 vol $4.16 each |
||
| Filed 2017-04-07 Tx date 2016-06-20 |
$VBV
VBI Vaccines Inc. |
Chawla, Sam
4 - Director of Issuer
Holder: Perceptive Life Sciences Master Fund Ltd. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$5,535,718
+1,362,370 vol $4.06 each |
2,829,359 | |
| Filed 2017-04-07 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
Anderson, David
5 - Senior Officer of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
57 - Exercise of rights
|
$-84,656.25
-21,875 vol $3.87 each |
65,625 | |
| Filed 2017-04-07 Tx date 2016-06-22 |
$VBV
VBI Vaccines Inc. |
Anderson, David
5 - Senior Officer of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
56 - Grant of rights
|
+87,500 vol |
87,500 | |
| Filed 2017-04-07 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
Anderson, David
5 - Senior Officer of Issuer
Direct Ownership
|
Subscription Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-07 Tx date 2016-12-19 |
$VBV
VBI Vaccines Inc. |
Anderson, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$32,549
+11,625 vol $2.80 each |
72,677 | |
| Filed 2017-04-05 Tx date 2016-12-06 |
$VBV
VBI Vaccines Inc. |
Perceptive Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Perceptive Life Sciences master Fund LTD (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
6,245,725 | ||
| Filed 2017-04-05 Tx date 2016-12-06 |
$VBV
VBI Vaccines Inc. |
Perceptive Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Titan Perc LTD (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
320,118 | ||
| Filed 2017-04-05 Tx date 2016-12-06 |
$VBV
VBI Vaccines Inc. |
Perceptive Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Titan Perc LTD (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-05 Tx date 2016-12-06 |
$VBV
VBI Vaccines Inc. |
Perceptive Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Perceptive Life Sciences master Fund LTD (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-05 Tx date 2016-12-06 |
$VBV
VBI Vaccines Inc. |
Perceptive Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Perceptive Life Sciences master Fund LTD (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-07 Tx date 2016-12-06 |
$VBV
VBI Vaccines Inc. |
Perceptive Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Perceptive Life Sciences master Fund LTD (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-07 Tx date 2016-12-06 |
$VBV
VBI Vaccines Inc. |
Perceptive Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Perceptive Life Sciences master Fund LTD (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
6,213,316 | ||
| Filed 2017-03-03 Tx date 2017-01-26 |
$VBV
VBI Vaccines Inc. |
Anderson, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
363,311 | |
| Filed 2017-03-02 Tx date 2017-01-26 |
$VBV
VBI Vaccines Inc. |
Diaz-Mitoma, Francisco
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
20,000 | |
| Filed 2017-03-02 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
Diaz-Mitoma, Francisco
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-02 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
Diaz-Mitoma, Francisco
5 - Senior Officer of Issuer
Holder: 1120962 Ontario Ltd. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
19,404 | ||
| Filed 2017-03-02 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
Diaz-Mitoma, Francisco
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
239,339 | ||
| Filed 2017-03-02 Tx date 2017-01-26 |
$VBV
VBI Vaccines Inc. |
De Wilde, Michel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,500 vol |
54,116 | |
| Filed 2017-03-02 Tx date 2017-01-26 |
$VBV
VBI Vaccines Inc. |
Chawla, Sam
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,500 vol |
54,116 | |
| Filed 2017-03-02 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
Chawla, Sam
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
41,616 | ||
| Filed 2017-03-02 Tx date 2016-12-07 |
$VBV
VBI Vaccines Inc. |
Chawla, Sam
4 - Director of Issuer
Holder: Titan Perc, Ltd. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$277,687
+91,045 vol $3.05 each |
320,118 | |
| Filed 2017-03-02 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
Chawla, Sam
4 - Director of Issuer
Holder: Titan Perc, Ltd. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
229,073 | ||
| Filed 2017-03-02 Tx date 2016-12-07 |
$VBV
VBI Vaccines Inc. |
Chawla, Sam
4 - Director of Issuer
Holder: Perceptive Life Sciences Master Fund Ltd. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$10,321,062
+3,383,955 vol $3.05 each |
6,213,314 | |
| Filed 2017-03-02 Tx date 2016-06-21 |
$VBV
VBI Vaccines Inc. |
Chawla, Sam
4 - Director of Issuer
Holder: Perceptive Life Sciences Master Fund Ltd. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$5,670,728
+1,362,370 vol $4.16 each |
2,829,359 | |
| Filed 2017-03-02 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
Chawla, Sam
4 - Director of Issuer
Holder: Perceptive Life Sciences Master Fund Ltd. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,466,989 | ||
| Filed 2017-03-02 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
Chawla, Sam
4 - Director of Issuer
Holder: Perceptive Life Sciences Master Fund Ltd. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-02 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
Chawla, Sam
4 - Director of Issuer
Holder: Perceptive Life Sciences Master Fund Ltd. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-02 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
Anderson, David
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-02 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
Anderson, David
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-02 Tx date 2016-05-05 |
$VBV
VBI Vaccines Inc. |
Anderson, David
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-02 Tx date 2016-12-19 |
$VBV
VBI Vaccines Inc. |
Anderson, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-32,550
-11,625 vol $2.80 each |
343,311 | |
| Filed 2017-03-02 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
Anderson, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
354,936 | ||
| Filed 2017-03-02 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
De Wilde, Michel
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
41,616 | ||
| Filed 2017-03-02 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
Anderson, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
48,932 | ||
| Filed 2017-03-02 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
Nascimento, Egidio
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
273,991 | ||
| Filed 2017-03-02 Tx date 2016-05-06 |
$VBV
VBI Vaccines Inc. |
Nascimento, Egidio
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,968 | ||
| Filed 2016-12-15 Tx date 2016-12-06 |
$VBV
VBI Vaccines Inc. |
Perceptive Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Perceptive Credit Holdings LP (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
2,068,824 | ||
| Filed 2016-12-15 Tx date 2016-12-06 |
$VBV
VBI Vaccines Inc. |
Perceptive Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Perceptive Life Sciences master Fund LTD (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
6,213,314 | ||
| Filed 2016-12-15 Tx date 2016-12-06 |
$VBV
VBI Vaccines Inc. |
Perceptive Advisors LLC
3 - 10% Security Holder of Issuer
Holder: Titan Perc LTD (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
320,119 |